Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Louis E. Schroder"'
Autor:
E. David Crawford, Mario A. Eisenberger, Burton M. Needles, Neel Hammond, Thomas E. Seay, Robert C. Flanigan, Danika Lew, Louis E. Schroder
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 6:145-148
Twenty-two eligible patients with advanced renal carcinoma were treated with suramin utilizing a fixed dose regimen. Therapy was reasonably well tolerated with 3 of 22 patients (14%) developing grade 4 toxicity and 11 of 22 patients (50%) having a ma
Publikováno v:
Archives of Pathology & Laboratory Medicine. 125:954-957
Allergic granulomatosis is a disorder of obscure etiology characterized by infiltration of lymph nodes with histiocytic granulomas and eosinophils. In this report, we describe a case of allergic granulomatosis that is consistent with Churg-Strauss di
Autor:
Louis E. Schroder, Brent A. Blumenstein, E. David Crawford, Robert L. Flanigan, James R. Borst
Publikováno v:
Urologic oncology. 3(3)
Doxorubicin/vinblastine combined with the P-glycoprotein inhibitors trifluoperazine and verapamil was evaluated in the treatment of patients with metastatic renal carcinoma. Patients were treated with starting doses of doxorubicin/vinblastine of 30 m
Publikováno v:
Clinical Nuclear Medicine. 17:41-44
Single intravenous injections of 30 to 35 mCi (1,110 to 1,295 MBq) of Re-186(Sn)HEDP previously have been shown to result in palliation of painful skeletal metastases from prostate cancer. There are no reports of patients receiving repetitive Re-186(
Autor:
Robert Chapman, Manuel Modiano, David R. Gandara, Joth Jacobson, John S. Macdonald, Louis E. Schroder, Dennis F. Moore
Publikováno v:
Investigational new drugs. 18(3)
Chemotherapeutic treatments using combinations of etoposide, leucovorin and 5-FU (ELF) have shown activity in the treatment of gastrointestinal malignancies. Interferon alpha 2b is known to have antiproliferative effects on several cell lines and has
Autor:
John Crowley, Kenneth R. Hande, Stanley P. Balcerzak, Derick H Lau, Steven M. Grunberg, Nikhil C. Munshi, Louis E. Schroder, Dori Giroux, Mark H. Zangmeister, Harry E. Hynes, David R. Gandara
Publikováno v:
Cancer chemotherapy and pharmacology. 44(6)
Purpose: An all-oral regimen of etoposide and cyclophosphamide was developed for use in poor-prognosis extensive disease small-cell lung cancer. Limited pharmacokinetic sampling was used to derive a pharmacodynamic model predictive of myelosuppressio
Autor:
Ranasinghange Samaratunga, Gary J. Ehrhardt, Louis E. Schroder, Harold J. Schneider, Emanuela E. Englaro, Edward Deutsch, Stephen R. Thomas, Karen F. Deutsch, Vicki S. Hertzberg, Harry R. Maxon, Craig C. Williams, Jonathan S. Moulton, Howard I. Scher
Publikováno v:
Seminars in nuclear medicine. 22(1)
Rhenium-186 (tin)hydroxyethylidene diphosphonate (HEDP) is a new radiopharmaceutical that localizes in skeletal metastases in patients with advanced cancer. A single intravenous administration of approximately 34 mCi (1,258 MBq) resulted in significa
Publikováno v:
American journal of clinical oncology. 14(1)
A prospective nonrandomized phase II study was begun in 1985 using concurrent split-course radiation and chemotherapy in the treatment of locally advanced non-small-cell cancer of the lung. Patients were treated with 3,000 cGy of radiation in 15 frac
Autor:
Vicki S. Hertzberg, Thomas, Maxon Hr rd, Louis E. Schroder, R.C. Samaratunga, K. F. Libson, Howard I. Scher, Craig C. Williams, Jonathan S. Moulton, Edward Deutsch
Publikováno v:
Radiology. 176(1)
Rhenium-186(tin) hydroxyethylidene diphosphonate (HEDP) is a new radiopharmaceutical that localizes in areas of osseous metastases in a manner similar to that of standard bone-scanning agents. It also emits beta particles with sufficient energy to be
Autor:
Louis E. Schroder, Richard W. Vilter
Publikováno v:
Archives of Internal Medicine. 143:1020
• Bilateral ureteral obstruction from uric acid stones developed in a patient with severe autoimmune hemolytic anemia at a time of hemolytic crisis. She had an underlying lymphoma that was clinically inapparent. Patients with severe autoimmune hemo